Impact of Covid-19 in Tropical Medicine
COVID-19 infection leads to intestinal infection. Studies have cultured the COVID-19 virus from a single stool specimen. No reports of faecal−oral transmission of the COVID-19 virus have been found. Drug researchers realise the harmful effect a virus can have on people’s health and the entire world economy. Neglected tropical diseases are bacterial, viral, parasitic, fungal and non-communicable origin. NTDs share a common geographical and social context: their burden is predominantly located in tropical areas across the globe, and they majorly affect resource-poor communities and their correlation with the poverty is so close. The epidemiology of NTDs is complex and relates to environmental conditions.
- NTD prevention
- Conspiracy theory
- Major Outbreaks
Related Conference of Impact of Covid-19 in Tropical Medicine
11th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
5th International conference on Vaccines, Vaccination and Immunization
Impact of Covid-19 in Tropical Medicine Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Antibiotic Prophylaxis - Antibiotics 2024 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2024 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2024 (UK)
- Antibiotics - Antibiotics 2024 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2024 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2024 (UK)
- Antimicrobial Peptides - Antibiotics 2024 (UK)
- Antimicrobial Therapy - Antibiotics 2024 (UK)
- Cancer Immunology and Immunotherapy - IMMUNOLOGY 2024 (Spain)
- Cell & Plant Biology - IMMUNOLOGY 2024 (Spain)
- Cell Biology - IMMUNOLOGY 2024 (Spain)
- CELL, ANIMAL & PLANT BIOLOGY - IMMUNOLOGY 2024 (Spain)
- Clinical Immunology & Current & Future Research - IMMUNOLOGY 2024 (Spain)
- Clinical Trials of Antibiotics - Antibiotics 2024 (UK)
- Current research in antibiotic resistance - Antibiotics 2024 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2024 (UK)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2024 (UK)
- Immune System - IMMUNOLOGY 2024 (Spain)
- Immuno informatics & Systems immunology - IMMUNOLOGY 2024 (Spain)
- Immuno-Genetics - IMMUNOLOGY 2024 (Spain)
- Immunogenetics - IMMUNOLOGY 2024 (Spain)
- Immunohistochemistry - IMMUNOLOGY 2024 (Spain)
- Immunology - IMMUNOLOGY 2024 (Spain)
- Immunology & Vaccines - Antibiotics 2024 (UK)
- Immunotherapy - IMMUNOLOGY 2024 (Spain)
- Infectious Diseases - Antibiotics 2024 (UK)
- Mechanism and Evolution of Antibiotic Resistance - Antibiotics 2024 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2024 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2024 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2024 (UK)
- New antibiotics and non-antibiotic approaches - Antibiotics 2024 (UK)
- Nutritional Immunology - IMMUNOLOGY 2024 (Spain)
- OncoImmunology - IMMUNOLOGY 2024 (Spain)
- Pediatric and Neonatal Immunology - IMMUNOLOGY 2024 (Spain)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2024 (UK)
- Pharmacology & Toxicology - Antibiotics 2024 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2024 (UK)
- Reproductive Immunology - IMMUNOLOGY 2024 (Spain)
- The Next Generation Approach of Antibiotics - Antibiotics 2024 (UK)
- Transplantation and Computational Immunology - IMMUNOLOGY 2024 (Spain)
- Vaccines & Immunization - IMMUNOLOGY 2024 (Spain)
- Virology and infectious diseases - IMMUNOLOGY 2024 (Spain)